Showing results (331-340 of 847) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|February 18, 2026
Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventionsIsabella Pahulu, Matthew Calumpit, Paul Tominez, et al.
JNCI Cancer Spectrum|March 4, 2025
The mediating role of physical activity on cognitive disparities in cancer survivorsJaimi L Allen, Laura Q Rogers, Michelle Y Martin, et al.
JNCI Cancer Spectrum|November 8, 2024
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetesNikhil Grandhi, Lawrence Liu, Mei Wang, et al.
JNCI Cancer Spectrum|March 20, 2025
Easy ensemble classifier-group and intersectional fairness and threshold (EEC-GIFT): a fairness-aware machine learning framework for lung cancer screening eligibility using real-world dataPiyawan Conahan, Lary A Robinson, Trung Le, et al.
JNCI Cancer Spectrum|October 23, 2024
Trends in age and prostate-specific antigen at prostate cancer diagnosis between 2010 and 2019Lukas Owens, Ojas Brahme, Roman Gulati, et al.
JNCI Cancer Spectrum|October 24, 2024
Narrative review of lifestyle interventions in breast cancer survivors: current evidence and future directionsKelsey Gabel, Kaitlin Chakos, Manoela Lima Oliveira, et al.
JNCI Cancer Spectrum|October 4, 2024
Characterization of undifferentiated carcinomas of the pancreas with and without osteoclast-like giant cellsJamie N Mills, Valerie Gunchick, Jake McGue, et al.
JNCI Cancer Spectrum|October 3, 2024
The intersection of travel burdens and financial hardship in cancer care: a scoping reviewArrianna Marie Planey, Lisa P Spees, Caitlin B Biddell, et al.
JNCI Cancer Spectrum|October 4, 2024
Germline reflex BRCA1/2 testing following tumor-only comprehensive genomic profiling: why, when, and howGiulia Maneri, Camilla Nero, Luciano Giacò, et al.
JNCI Cancer Spectrum|August 12, 2024
Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapyRebecca Forman, Jessica B Long, Sarah J Westvold, et al.
Pageof 85